The third and final installment of the Overcoming Challenges to UK Biobanking webinar series expands to bring together global industry leaders from large pharma with key stakeholders in biobanking to address some of the questions and concerns that often arise when working together. Speakers from AstraZeneca, Novartis and UKCRC will offer their unique insights and suggestions on the relationship between biobanks and the industry.
- The value of HBS for industry
- The importance of HBS compliance and traceability for industry
- The benefits of industry and biobanking interactions
This talk will be hosted by Scientist.com’s VP of Compliance & Categories, Matt McLoughlin.